Comparing Ki67 Levels in Breast Cancer Biopsies and Surgical Samples
Author Information
Author(s): Romero Quinci, Bendahl Pär-Ola, Klintman Marie, Loman Niklas, Ingvar Christian, Rydén Lisa, Rose Carsten, Grabau Dorthe, Borgquist Signe
Primary Institution: Skåne University Hospital, Lund, Sweden
Hypothesis
Are there differences in Ki67 proliferation scores between core biopsies and surgical samples in untreated breast cancer patients?
Conclusion
Core biopsies show significantly higher Ki67 proliferation values compared to surgical samples, even without any intervening therapy.
Supporting Evidence
- Core biopsies had an average proliferation difference of 3.9% higher than surgical samples.
- The difference was significant with a p-value of 0.046 using a paired t-test.
- Dichotomization at 20% showed 12 of 50 sample pairs had discrepant proliferation status.
Takeaway
This study found that samples taken from breast cancer biopsies grow faster than those taken during surgery, which is important for understanding cancer treatment.
Methodology
Fifty breast cancer cases were analyzed for Ki67 expression in both core biopsies and surgical samples using immunohistochemistry.
Potential Biases
Potential biases may arise from sample handling and the selection of tumor regions for analysis.
Limitations
The study is retrospective and may not account for all variables affecting Ki67 expression.
Participant Demographics
Median age of participants was 63 years, with a range from 25 to 88 years.
Statistical Information
P-Value
0.046
Confidence Interval
0.1-7.8%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website